The rational design and synthesis of haptens having specific activity as full agonists or full antagonists at the benzodiazepine receptor.
The use of computer graphics hardware, in conjunction with molecular modeling software, has allowed for a structural analysis of compounds that bind to the benzodiazepine receptor (BZR) in the nM range. The definition of additional binding requirements together with steric and/or hydrophobic limitations has been directly correlated with profiles of in vivo activity, both for full agonists and full antagonists. This information has been used for the rational design of haptens that contain the antigenic determinants necessary for the production of antibodies specific for either full agonists or for full antagonists at the BZR. The synthesis of these novel compounds has been completed.
Fryer
R I
RI
Rutgers, State University of New Jersey, Department of Chemistry, Carl A. Olson Laboratory, Newark 07102.
Gu
Z Q
ZQ
D000818:Animals; D015195:Drug Design; D006241:Haptens / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D008024:Ligands; D015394:Molecular Structure; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism*; D013329:Structure-Activity Relationship
D006241:Haptens; D008024:Ligands; D011963:Receptors, GABA-A